Prolonged maintenance therapy by low dose interferon for HCV patients with chronic liver disease
Arase, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 284-289
2015
ISSN/ISBN: 0047-1852 PMID: 26845946 Document Number: 683288
Document emailed within 1 workday
Related Documents
Di Costanzo, G.G.; Ascione, A.; Lanza, A.G.; De Luca, M.; Bracco, A.; Lojodice, D.; Marsilia, G.M.; Ferbo, U. 1996: Resistance to alpha interferon therapy in HCV chronic liver disease: role of hepatic fibrosis Italian Journal of Gastroenterology 28(3): 140-146Ellis, C.N.; Fradin, M.S.; Hamilton, T.A.; Voorhees, J.J. 1995: Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy Archives of Dermatology 131(7): 791-795
Mayet, I.Y. 1990: Low-dose zinc therapy for maintenance treatment of Wilson's disease Clinical Pharmacy 9(12): 951-953
Lejeune, P.; Desager, J.P.; Meunier, H.; Harvengt, C. 1988: Kinetics of a single dose combination of nifedipine/acebutolol in patients with chronic liver disease International Journal of Clinical Pharmacology Therapy and Toxicology 26(10): 513-516
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Guilhot, F. 1993: Interferon alfa and low-dose cytosine-arabinoside for the treatment of patients with chronic myelogenous leukemia in chronic phase. French CML Study Group Seminars in Hematology 30(3 Suppl 3: 24-25
Bilhou-Nabéra, C.; Marit, G.; Gharbi, M.J.; Salzes, S.; Mahon, F.X.; Broustet, A.; Reiffers, J.; Bernard, P. 1995: Chronic myelocytic leukemia patients achieving complete cytogenetic conversion under interferon alpha therapy: minimal residual disease follow-up Leukemia 9(12): 2067-2070
Müting, D.; Dohn, P.; Reikowski, J. 1972: Effect of high-dose, intravenous and oral administration of essential phospholipids on protein and lipid metabolism as well as enzyme activities in patients with chronic liver disease Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 1389-1392
Recchia, F.; Cesta, A.; Rea, S. 2003: Low dose interleukin-2 and 13-cis-retinoic acid as maintenance therapy in patients with solid tumors responsive to chemotherapy Journal of Experimental and Clinical Cancer Research: Cr 22(4 Suppl): 135-143
Mule, A.; Sirohi, P.; Ram, N. 2018: Prevalence of Chronic Liver Disease Among the Patients of Celiac Disease and Effect of Gluten-Free Diet on Outcome of Liver Disease: a Prospective Study Journal of the Association of Physicians of India 66(3): 34-36
Winkler, M.; Ringe, B.; Jost, U.; Gubernatis, G.; Pichlmayr, R. 1993: Plasma level-guided low-dose FK 506 therapy in patients with early liver dysfunction after liver transplantation Transplantation Proceedings 25(4): 2688-2690
Armenta, D.; Espallargas, C.; Paz, A.; Rodríguez Martorel, J.; Ladines, R.; Alvarez, C.; Román, J.; Andrés, P. 1996: Complete cytogenetic remission of chronic myeloid leukemia with low-dose interferon alfa-2b and monthly high-dose busulfan Sangre 41(6): 465-467
Onal, S.; Kazokoglu, H.; Koç, A.; Akman, M.; Bavbek, T.; Direskeneli, H.; Yavuz, S. 2009: Low dose and dose escalating therapy of interferon alfa-2a in the treatment of refractory and sight-threatening Behçet's uveitis Clinical and Experimental Rheumatology 27(2 Suppl 53: S113-S114
Niiya, F.; Ikeda, S.; Nagata, S.; Iwamoto, M.; Shirouzu, K. 2001: A case of advanced gastric cancer complicated with liver metastases responding remarkably to combined chemotherapy with 5-fluorouracil and low-dose cisplatin, with UFT and low-dose cisplatin for maintenance on an outpatient basis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(3): 391-394
Abu-Elmagd, K.M.; Aly, M.A.; Fathy, O.M.; E-Ghawlby, N.A.; el-Fiky, A.M.; el-Barbary, M.H.; el-Hak, N.G.; el-Ebady, G.E.; Sultan, A.; Bahgat, O.O. 1993: Ten years of experience with patients with chronic active liver disease variceal bleeding: ablative versus selective decompressive therapy Surgery 114(5): 868-881
Virukalpattigopalratnam, M.P.; Singh, T.; Ravishankar, A.C. 2013: Heptral (ademetionine) in patients with intrahepatic cholestasis in chronic liver disease due to non-alcoholic liver disease: results of a multicentre observational study in India Journal of the Indian Medical Association 111(12): 856-859
Gheorghiade, M.; Hall, V.B.; Jacobsen, G.; Alam, M.; Rosman, H.; Goldstein, S. 1995: Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors Circulation 92(7): 1801-1807
Cervantes, F.; Hernández-Boluda, J-Carlos.; Steegmann, J-Luis.; Conde, E.; Alvarez-Larrán, A.; López-Jiménez, J.; Osorio, S.; Villalón, Lía.; Camós, M.; García-Conde, J.; Odriozola, Jús. 2003: Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients Haematologica 88(10): 1117-1122
Niederau, C.; Heintges, T.; Niederau, M.; Stremmel, W.; Strohmeyer, G. 1993: Selection of patients with chronic hepatitis B for therapy with alpha-interferon Zeitschrift für Arztliche Fortbildung 87(4): 273-278
Soriano, V.; García-Samaniego, J. 1994: Therapy with interferon in HIV-infected patients with chronic viral hepatitis Revista Clinica Espanola 194(10): 887-889